Originally posted February 2, 2026
Read how MCIDT affiliates Tim Cernak and Adam Lauring are working together to develop novel drug solutions to outbreaks of highly pathogenic avian influenza subtype H5Nx.
Originally posted February 2, 2026
Read how MCIDT affiliates Tim Cernak and Adam Lauring are working together to develop novel drug solutions to outbreaks of highly pathogenic avian influenza subtype H5Nx.